
CRISPR Therapeutics (NASDAQ:CRSP) has outperformed the market over the past 5 years by 12.09% on an annualized basis producing an average annual return of 26.02%. Currently, CRISPR Therapeutics has a market capitalization of $5.12 billion.
Buying $1000 In CRSP: If an investor had bought $1000 of CRSP stock 5 years ago, it would be worth $3,073.58 today based on a price of $66.46 for CRSP at the time of writing.